The use of a cutaneous vasoconstrictor agent is helpful in many branches of surgery. This report deals with the use of a new vasoconstrictor agent (ornithine vasopressin —POR 8) in a range of general surgical procedures. It was found to be both effective and safe, with practically no side‐effects. Extension of its clinical use is recommended.
No takes yet. Share an insight, caveat, or question.
John G. McCaffrey (1970) studied this question.